Single-use lumen-apposing metal stent (LAMS) endoscope

The single-use endoscope system with suction-based tissue fixation and RF energy delivery addresses the challenges of stabilizing mobile structures and deploying LAMS efficiently, enhancing procedural precision and reducing complications in endoscopic procedures.

WO2026236330A1PCT designated stage Publication Date: 2026-11-12GYRUS ACMI INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/US2026/026857
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-06
Filing Date
2026-05-06
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Endoscopic procedures for creating connections between adjacent body lumens, such as in EUS-GE, face challenges with stabilizing mobile structures like the small intestine, maintaining proper alignment during puncture, preventing fluid leakage, and requiring multiple specialized tools, leading to increased procedural complexity and risks.

Method used

A single-use endoscope system with integrated suction-based tissue fixation and RF energy delivery, allowing for precise deployment of a pre-installed LAMS, which includes a tapered distal tip with electrodes and suction ports to stabilize tissue and deploy stents sequentially, reducing the need for multiple tools and steps.

Benefits of technology

The system enables stable, precise, and efficient deployment of LAMS between lumens, minimizing fluid leakage and procedural time, while improving stent placement accuracy and reducing complications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure US2026026857_12112026_PF_FP_ABST
    Figure US2026026857_12112026_PF_FP_ABST
Patent Text Reader

Abstract

An endoscopic system for creating a connection between adjacent body lumens can include an endoscope with a tapered distal tip, a suction port defining one or more openings at the distal tip, and one or more electrodes positioned around the suction port. The electrodes can deliver radiofrequency energy while suction draws tissue against the distal tip to form a controlled opening in the tissue. A lumen-apposing stent can be mounted on the endoscope near the distal tip and can include a proximal portion and a distal portion. A deploy line extending along the endoscope can restrain the stent and, upon actuation such as by a handle, can release the proximal portion independently of the distal portion. A visual indicator on the endoscope can assist with positioning the stent. The tapered distal tip may function as an electrode to enlarge the tissue opening.
Need to check novelty before this filing date? Find Prior Art

Description

SINGLE-USE LUMEN-APPOSING METAL STENT (LAMS) ENDOSCOPEPRIORITY CLAIM

[0001] This application claims the benefit of priority to U.S. Provisional Patent Application Serial No. 63 / 800,591, filed May 6, 2025, the contents of which are hereby incorporated by reference.TECHNICAL FIELD

[0002] The present disclosure involves systems and methods for creating connections between adjacent body lumens using an integrated endoscopic device with suction-based tissue fixation and controlled stent deployment capabilities.BACKGROUND

[0003] Some medical procedures involve creating connections between adjacent body lumens. In such procedures, tools and devices can be advanced through body lumens to deliver implants such as stents between organs. For example, some procedures can involve accessing target sites through the gastrointestinal tract to deliver stents or other devices between adjacent organs such as the intestines and stomach.

[0004] Endoscopic procedures may use precise control and visualization during navigation between organs. Tissue stabilization and proper implant placement present technical considerations. Different tools may be used to create and maintain connections between adjacent structures.SUMMARY

[0005] Endoscopic procedures such as inter-luminal procedures can be used to create connections between adjacent body lumens and can involve placement of tissue anchors or stents between the adjacent body lumens. One class of stents are lumen-apposing metal stents (LAMS). Endoscopic ultrasound-guided gastroenterostomy (EUS-GE) is a minimally invasive procedure used to create a bypass between the stomach and the small intestine, primarily forpatients suffering from gastric outlet obstruction (GOO), such as can be caused by a malignant tumor, benign stricture, or other condition that inhibits normal gastric emptying.

[0006] In some EUS-GE procedures, a bypass can be created by accessing the stomach and then the small intestine. Such an approach can be problematic as the small intestine can move around, making it difficult to find a location on the small intestine to cut a hole to complete the bypass. Thus, the target tissue can be difficult to stabilize, particularly with mobile structures like the small intestine. Maintaining proper alignment during puncture and preventing fluid leakage are ongoing concerns. Multiple specialized tools and steps may be used to perform these procedures, which can increase procedural complexity, leading to longer procedure times and risks such as infections. Misplaced LAMS or stent migration can present issues that can provoke additional procedures to correct, which can increase patient discomfort and / or increase healthcare costs.

[0007] Disclosed herein is a single-use endoscope system that can provide integrated functionality for creating connections between adjacent body lumens. The system can include a tapered distal tip with one or more electrodes positioned around a suction port. The electrodes can deliver radiofrequency (RF) energy while suction can be used to maintain tissue position. A pre-installed LAMS can be deployed in portions, for example sequentially, to create a stable connection between the adjacent lumens. For example, the proximal portion or side of the LAMS device can be deployed or expanded at a different point in the procedure, e.g., before or after the distal portion or side of the LAMS device. In example implementations, the proximal portion of the LAMS device can be deployed before the distal portion (e.g., in a proximal first organ). The scope can be advanced further until it reaches a point where the distal portion or side of the LAMS device can be deployed or expanded (in a more distal second organ). In this disclosure, pre-installed means that the LAMS device is presented with the endoscope. For example, the pre-installed LAMS can be attached to and / or mounted on an outer surface of the endoscope before the procedure begins. In some examples, the preinstalled LAMS can be deployed in a sheath that can be provided in a lumen of the endoscope. This configuration of the pre-installed LAMS can permit precise and immediate deployment and / or can permit deployment with separate insertion or assembly steps.

[0008] The system can help enable direct visualization during navigation and deployment. The integrated suction capability can help inhibit or reduce fluid leakage throughout the procedure. A visual indicator can be included to assist with proper positioning. As such, the presently disclosed single device can integrate multiple functions to streamline the procedure.GAP25085-GIIV-WO1 (5409.A05W01) 2

[0009] Suction-based tissue fixation can help provide stability before, during, and / or after tissue penetration. RF energy combined with maintained suction can help allow for controlled tissue penetration while inhibiting fluid leakage, e.g., leakage to / from the abdominal cavity and / or the organs being penetrated. In some examples, the suction can be used to manipulate tissue walls of separate organs (e.g., the walls of the stomach and the small intestine) relative to each other. In an example, instead of going through the stomach into the small intestine to create the bypass, a physician can go through the small intestine, use suction to “grasp” the wall of the small intestine, cut the bypass hole in the small intestine, and then use suction to “grasp” the wall of the stomach and cut the bypass hole in the wall of the stomach. In such an example, the proximal flange of the LAMS can be deployed in the small intestine first, and the distal flange can be deployed in the stomach to create the bypass. The pre-installed LAMS with the example proximal-first flange deployment can help to assist with proper stent placement. Direct visualization capabilities can help avoid nearby structures or tissue during navigation.

[0010] The present disclosure provides methods and apparatus for establishing transluminal access between a first body lumen and a second body lumen. Such transluminal access may be used for any medical purpose, including for performing transluminal therapeutic endoscopy where the first body lumen can be within the gastrointestinal (GI) tract, including the esophagus, the stomach, the duodenum, the small intestines, and the large intestines. The second body lumen, which is the target of the access, can be an organ or other tissue structure which lies adjacent to the gastrointestinal tract (or may be another part of the GI tract), including the bile duct, the pancreatic duct, the gallbladder, cysts, pseudocysts, abscesses, the pancreas, the liver, the urinary bladder, the duodenum, jejunum, and colon. Particular procedures which may benefit from the access methods and apparatus discussed herein include gastrojejunostomy, gastroduodenostomy, and gastrocolostomy. Other procedures which can benefit from the methods and apparatus discussed herein include vascular bypass including portosystemic shunts and transjugular intrahepatic portasystemic shunt (TIPS) procedures. The procedures may use ultrasound sonography.

[0011] The methods and systems of the present disclosure can be advantageous in procedures such as those discussed above in a number of ways. For example, in implementations in which the LAMS is carried by the endoscope itself, the endoscope can provide a stable platform for penetrating the luminal walls, maintaining the luminal walls in apposition, and deploying the LAMS while the luminal walls are maintained in apposition. In alternative implementations, a stent deployment catheter can be docked with or coupled to the endoscope introduced to the first body lumen to provide a stable platform for sequentially accessing tools to penetrate the GAP25085-GIIV-WO1 (5409.A05W01) 3luminal walls, maintain the luminal walls in apposition, and deploy the stent while the luminal walls are maintained in apposition. In some examples, by deploying a penetrating needle from the endoscope or the stent placement catheter to form the initial penetration and subsequently introducing the stent delivery tool(s) over the needle using the same catheter or the endoscope, the duration of the procedure can be reduced and the exchange of tools over the guidewire can be reduced, or in some cases, avoided. An advantage provided by the methods and apparatus discussed herein is the ability to use suction to connect to, join, link with, manipulate and / or stabilize luminal walls to permit more accurate and precise deployment of tools to penetrate the luminal walls and / or contribute to forming a physical relationship between the stent and the tissue. By employing suction from the endoscope or the catheter on a proximal side of the luminal walls of the first and / or second body lumen prior to, during or after penetration, the tip of the endoscope or the catheter can obtain and maintain a fixed relationship with the luminal walls. The use of suction can permit the endoscope or the catheter to attach to the luminal walls, which can be urged in a proximal or distal direction (e.g., pushed or pulled), and can be urged toward a proximal side of a partially deployed stent to hold the luminal walls in apposition while a distal side of the stent is deployed. In an example, the endoscope or the catheter can be configured to provide suction at the tip, or at the circumference. The suction can be radially or transversely directed. The suction can be implemented through a portion of the stent to contribute to drawing the tissue to the stent.

[0012] The stents that are deployed by the methods and apparatus discussed herein include distal and proximal flange elements which, at the end of the implantation procedure, engage the luminal walls and hold the luminal walls together. In addition, the flanges and stent seal sufficiently against the luminal walls to inhibit leakage. The stent can include or define a central opening or passage to allow the exchange of fluid between the first body lumen and the second body lumen, for example, drainage of fluid from the second body lumen into the first body lumen, e.g., for gallbladder or bile duct drainage.

[0013] According to an alternative example, a separate delivery device can be used to deliver a tissue stent in a controlled and predetermined manner. The controlled delivery device can be introduced through the working channel of an endoscope and can include a proximal handle that provides control of delivery and a catheter that extends from a distal end of the proximal handle to the distal end of the device. The handle can include a coupling member for removable attachment to the endoscope to provide a stable deployable platform. The catheter can include an outer sheath, at least one shaft (e.g., an inner catheter or pusher tube) that can be used to deploy the stent, and a distal tip. The handle can include coaxial sliding elements that can GAP25085-GIIV-WO1 (5409.A05W01) 4control at least three operations, including device catheter positioning, proximal stent flange deployment, and distal stent flange deployment. Such devices and apparatus can include a first lock and a second lock for securing the first sliding element and the second sliding element, respectively. The ability to lock the sliding elements can allow deployment of other components of the apparatus while maintaining the same relative position of the locked components.

[0014] In such an example, the shaft and sheath of the catheter of the apparatus can be coaxially disposed so that the stent may be held over the shaft and constrained by the sheath. The stent can be self-expanding, so that the flanges can be deployed by moving the sheath relative to the shaft. The distal side of the stent can be constrained when the proximal side of the stent is deployed, and / or vice-versa. Alternatively, or in addition, both sides of the stent can be deployed at once. As described in more detail below, this configuration can permit the distal and / or proximal flange to be deployed and urged against a luminal wall to maintain apposition of the luminal walls during the stent implantation.

[0015] The endoscope or catheter shaft can include an axial passage extending therethrough. In some examples, the axial passage can be adapted to receive a guidewire and / or a needle which can be slidably disposed in the axial passage of the shaft. The needle can include a tissue penetrating tip, which can be sharpened, pointed or include an electrosurgical element, or other tissue cutting or penetrating device. After penetrating the luminal walls, the shaft and sheath of the catheter can be advanced over the needle to pass through the penetration in the luminal walls. The distal tip of the endoscope or catheter shaft can be tapered or have a cutting element or other operative configuration to facilitate opening or expanding the passage through the luminal walls. The sheath can be moved relative to the shaft to deploy the stent as discussed above.

[0016] An example method for placement of a stent between a first body lumen and a second body lumen can include advancing an endoscope to a proximal side of the first lumen. In an example, the endoscope can carry the stent at or near a distal tip of the endoscope. In an alternative example, the endoscope can include a stent deployment catheter that can be advanced through a working channel of the endoscope, and a handle control mechanism on the stent deployment catheter can be attached to the endoscope so that the handle can be immobilized relative to the endoscope. If used, a stent deployment catheter assembly can include a shaft, a self-expanding stent (or anchor structure) carried on the shaft, and a sheath constraining the stent on the shaft, and the handle can be used to sequentially manipulate the various catheter components to deploy the stent. The endoscope or catheter assembly can be GAP25085-GIIV-WO1 (5409.A05W01) 5advanced to a proximal wall of the first body lumen, and a proximal side of the stent can be deployed by manipulating the sheath to free the proximal flange of the stent. Suction can be applied through the endoscope or the catheter to the first luminal wall, which can be used to urge (e.g., to pull) the wall toward the deployed flange. The endoscope or catheter can be advanced to maintain contact between the proximal flange and the first luminal wall. An opening can be formed through the first luminal wall, and the endoscope or catheter can be advanced through the opening to the second luminal wall. Suction can be applied through the endoscope or the catheter to the second luminal wall, which can urge (e.g., to pull) the second wall in a proximal direction. The endoscope or the catheter can be advanced to urge (e.g., to push) the deployed flange and first luminal wall toward the second luminal wall to make the walls apposed to each other.

[0017] An opening can be formed through the second luminal wall, and the endoscope or the catheter can be advanced through the opening to extend beyond the second luminal wall. The distal flange of the stent can be deployed in the second body lumen by actuating a deploy line on the endoscope, or by manipulating a sheath on the catheter, to release the distal portion of the stent, which can expand to form the flange. The endoscope or the stent deployment assembly can be urged in a distal direction to permit the flange to fully expand and engage a distal side of the second luminal wall and bring the two luminal walls into closer apposition. The endoscope or the catheter may then be withdrawn, leaving the deployed stent in place.

[0018] Another example for a LAMS placement method can include the use of ultrasound sonography, such as endoscopic ultrasound sonography (EUS), or fluoroscopy to locate the position where stent should be placed.

[0019] Another example for a LAMS placement method can include advancing an endoscope tip towards the location, advancing the endoscope or a catheter from the endoscope distally toward the first tissue and deploying a proximal side of the stent from the endoscope or the catheter to form a proximal flange. Suction can be applied at the endoscope tip to the tissue location to grasp and / or stabilize a first tissue. A wall of the first tissue can be pulled to the proximal side of the stent with the suction. Alternatively, or in addition, the endoscope, catheter, and / or proximal flange can be advanced to urge the proximal flange toward the first tissue wall (e.g., a wall of the first tissue).

[0020] An opening can be formed in the first tissue wall near the endoscope tip at a desired location. Suction may be employed or not during opening formation, as desired or necessary. An electric powered (e.g., an RF) cutting tool can be used to form the opening. For example, the cutting tool can be a cannulated RF electrode tip. Other opening forming techniques such GAP25085-GIIV-WO1 (5409.A05W01) 6as puncturing the first tissue wall with a needle may be employed to form the opening. In other examples, opening formation techniques can include using movable or fixed blades, rotational cutting, or the like.

[0021] The method can further include advancing the endoscope or advancing the catheter tip through the opening to a second tissue, applying suction at the endoscope or catheter tip to grasp and / or stabilize the second tissue, and pulling a wall of the second tissue (a second tissue wall) with suction. Alternatively, or in addition, the endoscope, the catheter and / or proximal flange can be advanced to urge the first tissue wall toward the second tissue wall to place the tissue walls in an apposing state. The method can further include forming an opening in the second tissue wall near the endoscope or catheter tip at a desired location. As with forming the opening in the first tissue wall, suction can be used or not during the formation of the opening in the second tissue wall as desired or appropriate. Also as with forming the opening in the first tissue wall, the opening in the second tissue wall can be formed using an RF cutting tool, needle, blade, or using any appropriate tool or technique.

[0022] The method can further include advancing the endoscope or catheter tip through an opening in the second tissue wall. In such an example, the endoscope, catheter or the proximal side of the stent can be advanced toward the second tissue wall to bring the first and second tissue walls near each other, close together, proximal to each other, or the like so that the first tissue wall and the second tissue wall can be held more securely. The method can further include deploying a distal side of the stent from the endoscope or catheter. Optionally, a gap length between the first and second luminal walls can be adjusted to more precisely and accurately fit the stent to the tissue walls and openings. The method can then include retracting the endoscope or catheter and leaving the deployed stent in place.

[0023] Features of the presently disclosed systems and methods can include suction via the same or different lumen of the endoscope or of the catheter used by the cutting tool. The use of suction can help stabilize the endoscope tip or the catheter tip on tissue and to help permit more accurate positioning of the cutting tool. Suction can also be used to pull a first tissue wall in the proximal direction to create a gap that permits forming an opening in the first tissue wall without impacting the second tissue wall. The edges of the stent end that face the tissue can include one or more protrusions that can help contribute to stabilizing the tissue and / or help contribute to the capturing effect of the suction on the tissue. Suction can also be used to remove fluid and debris at the surgical site or procedure location or to remove fluid and debris from the first or second luminal body, as desired or necessary.GAP25085-GIIV-WO1 (5409.A05W01) 7BRIEF DESCRIPTION OF THE DRAWINGS

[0024] In the drawings, which are not necessarily drawn to scale, like numerals may describe similar components in different views. Like numerals having different letter suffixes may represent different instances of similar components. The drawings illustrate generally, by way of example, but not by way of limitation, various embodiments discussed in the present document.

[0025] FIG. 1 illustrates an example of a schematic diagram of an endoscopy system including an imaging and control system and an endoscope.

[0026] FIG. 2 illustrates an example of a schematic diagram of the endoscopy system of FIG.1 including the endoscope connected to a control unit of the imaging and control system.

[0027] FIG. 3 illustrates example components of an endoscopic system including a suction port, electrode, deploy line, and LAMS with distal and proximal sides.

[0028] FIGS. 4A-4D illustrate an example flow of using the endoscopic system to create connections between body lumens.

[0029] FIG. 5 illustrates an example of manipulating a first tissue wall relative to a second tissue wall using a suction-based deployment device.

[0030] FIG. 6 illustrates an example of a deployment device positioned between a first tissue wall and a second tissue wall after penetrating through the first tissue wall.

[0031] FIG. 7 illustrates an example of a deployed stent with proximal and distal flanges engaging a first tissue wall and a second tissue wall, respectively.

[0032] FIG. 8 illustrates an example of a final deployed state of the LAMS after withdrawal of the deployment device.

[0033] FIG. 9 illustrates an example method for creating a connection between adjacent body lumens.DETAILED DESCRIPTION

[0034] An example endoscopic system can include an endoscope (used interchangeably herein with the term “scope”) assembly providing a scope with a tapered distal tip with a suction port that can be separate or integrated and an electrode. The electrode can be adjacent or abutting the suction port, and / or can be partially or wholly surrounded by the suction port. The electrode can be selectively energized to deliver RF energy for controlled tissue penetration. A LAMS device GAP25085-GIIV-WO1 (5409.A05W01) 8can be carried by the scope, such as to be included in and deployable from the scope assembly by being located, pre-installed, included, or the like near the distal end of the scope. In an example implementation, the LAMS device can be provided in a separate sheath or tool that is positioned within a lumen of the scope. The LAMS device can include proximal and distal portions, such as flanges, that can be deployed individually, separately, independently, or the like such as to allow them to be deployed concurrently or sequentially.

[0035] FIGS. 1 and 2 show an example of an endoscopy system. FIG. 1 is an example of a schematic diagram of an endoscopy system 10, and FIG. 2 is an example of a schematic diagram of the endoscopy system 10 including an endoscope 14 connected to a control unit of an imaging and control system 12. The endoscopy system 10 can include the imaging and control system 12 and the endoscope 14. The system of FIGS. 1 and 2 is an illustrative example of an endoscopy system suitable for use with the systems, devices, and methods described herein. According to some examples, the endoscope 14 can be insertable into an anatomical region for imaging and / or to provide passage of one or more sampling devices for biopsies, or one or more therapeutic devices for treatment of a disease state associated with the anatomical region. The endoscope 14 can interface with and connect to the imaging and control system 12. In examples, the endoscope 14 can be a single-use endoscope as described herein. Other types of endoscopes can be used with the features and teachings of the present disclosure.

[0036] The imaging and control system 12 can include a controller 16, an output unit 18, an input unit 20, a light source 22, a fluid source 24, and a suction pump 26. The imaging and control system 12 can include various ports for coupling with the endoscope 14. For example, the controller 16 can include a data input / output port for receiving data from and communicating data to the endoscope 14. The light source 22 can include an output port for transmitting light to the endoscope 14, such as via a fiber optic link. The fluid source 24 can include a port for transmitting fluid to the endoscope 14. The fluid source 24 can include a pump and a tank of fluid or can be connected to an external tank, vessel, or storage unit. The suction pump 26 can include a port used to draw a vacuum from the endoscope 14 to generate suction, such as for withdrawing fluid from the anatomical region into which the endoscope 14 is inserted, or for drawing tissue into contact with a distal end of the endoscope 14 as described herein. The output unit 18 and input unit 20 can be used by an operator of the endoscopy system 10 to control functions of the endoscopy system 10 and view output of the endoscope 14. The controller 16 can be used to generate signals or other outputs for treating the anatomical region into which the endoscope 14 is inserted. In examples, the controller 16 can generate electrical output, acoustic output, fluid GAP25085-GIIV-WO1 (5409.A05W01) 9output, and the like for treating the anatomical region with, for example, cauterizing, cutting, freezing, and the like.

[0037] The endoscope 14 can include an insertion section 28, a functional section 30, and a handle section 32, which can be coupled to a cable section 34 and a coupler section 36. The insertion section 28 can extend distally from the handle section 32, and the cable section 34 can extend proximally from the handle section 32. The insertion section 28 can be elongate and can include a bending section and a distal end to which the functional section 30 can be attached. The bending section can be controllable (e.g., by a control knob 38 on the handle section 32) to maneuver the distal end through anatomical passageways (e.g., stomach, duodenum, kidney, ureter, etc.). The insertion section 28 can include one or more working channels (e.g., an internal lumen) that can be elongate and support insertion of one or more therapeutic tools of the functional section 30. The working channel can extend between the handle section 32 and the functional section 30. Fluid passages, guide wires, and pull wires can be provided by the insertion section 28 (e.g., via suction or irrigation passageways, and the like).

[0038] The handle section 32 can include the knob 38 as well as ports 40. The knob 38 can be coupled to a pull wire extending through the insertion section 28. The ports 40 can be configured to couple various electrical cables, fluid tubes, and the like to the handle section 32 for coupling with the insertion section 28. In examples, a port 40 can be used to feed an auxiliary catheter, such as a sphincterotome or cannula, into the insertion section 28. In examples, a LAMS deployment catheter as described herein can be introduced through a port 40 and the working channel of the insertion section 28.

[0039] The imaging and control system 12, according to examples, can be provided on a mobile platform (e.g., a cart 41) with shelves for housing the light source 22, the suction pump 26, an image processing unit 42, etc. Alternatively, several components of the imaging and control system 12 shown in FIGS. 1 and 2 can be provided directly on the endoscope 14 so as to make the endoscope self-contained.

[0040] The functional section 30 can include components for treating and diagnosing anatomy of a patient. The functional section 30 can include an imaging device and an illumination device. The functional section 30 can include a distal tip of the endoscope 14 having a suction port and one or more electrodes as described herein with reference to FIG. 3.

[0041] As shown in FIG. 2, the imaging and control system 12 can include the controller 16, which can include or be coupled to the image processing unit 42, a treatment generator 44, and a GAP25085-GIIV-WO1 (5409.A05W01) 10drive unit 46, as well as the light source 22, the input unit 20, and the output unit 18. The image processing unit 42 and the light source 22 can each interface with the endoscope 14 (e.g., at the functional section 30) by wired or wireless electrical connections. The imaging and control system 12 can accordingly illuminate an anatomical region, collect signals representing the anatomical region, process signals representing the anatomical region, and display images representing the anatomical region on the output unit 18. The imaging and control system 12 can include the light source 22 to illuminate the anatomical region using light of a desired spectrum (e.g., broadband white light, narrow-band imaging using selected electromagnetic wavelengths, and the like). The imaging and control system 12 can connect (e.g., via an endoscope connector) to the endoscope 14 for signal transmission (e.g., light output from the light source, video signals from an imaging system in the distal end, diagnostic and sensor signals, and the like). The treatment generator 44 can provide energy to the one or more electrodes at the distal tip of the endoscope 14, such as RF energy for tissue penetration as described herein.

[0042] The fluid source 24 can include one or more sources of air, saline, or other fluids, as well as associated fluid pathways (e.g., air channels, irrigation channels, suction channels) and connectors (barb fittings, fluid seals, valves, and the like). The imaging and control system 12 can include the drive unit 46, which can be an optional component. The drive unit 46 can include a motorized drive for advancing a distal section of the endoscope 14.

[0043] FIG. 3 illustrates an example of an endoscope 300 for creating a connection between adjacent body lumens. The endoscope 300 can include an elongate shaft 302 extending along a longitudinal axis of the endoscope 300 and a tapered distal tip 304 at a distal end of the elongate shaft 302. A suction port 306 can be defined at the tapered distal tip 304 and can be connectable to a suction source for applying suction through the tapered distal tip 304. An electrode 308 can be positioned at the tapered distal tip 304 near and / or around an opening of the suction port 306 and can be connectable to an electrosurgical generator for delivering RF energy to tissue at or near the tapered distal tip 304. As such, the suction port 306 can define an opening in the tapered distal tip 304 and the electrode 308 can be positioned around the suction port 306 such that suction applied through the suction port 306 and RF energy delivered from the electrode 308 can act on a common tissue region, the same tissue, or the like. In some examples, the electrode 308 can be a single electrode extending around the suction port 306. In other examples, the electrode 308 can include a series of discrete electrodes arranged around the suction port 306. A portion of the tapered distal tip 304 can function as the electrode 308 or can include the electrode 308 suchGAP25085-GIIV-WO1 (5409.A05W01) 11that advancement of the tapered distal tip 304 through a tissue opening can enlarge the tissue opening.

[0044] The endoscope 300 can include a camera 310 and a light source 312 at or near the tapered distal tip 304. The camera 310 can capture images of an anatomical region for visualization during navigation and deployment. The camera 310 can be, for example, a CCD image sensor, a CMOS image sensor, or another image sensor. The light source 312 can provide illumination of the anatomical region for the camera 310. The light source 312 can include, for example, one or more LEDs or can be coupled to a fiber optic link to an external light source.

[0045] A LAMS 316 can be carried by the endoscope 300 near the tapered distal tip 304. In an example, the LAMS 316 can be pre-installed on the endoscope 300, such as by being attached to or mounted on an outer surface of the elongate shaft 302. In such an example, the LAMS 316 can include a designated proximal portion 318 and a designated distal portion 320. The proximal portion 318 and the distal portion 320 can be configured to be deployed independently of each other, such as concurrently or sequentially. In an example, the proximal portion 318 can be deployed before the distal portion 320.

[0046] One or more deploy lines such as deploy line 314 can extend along or otherwise be located on a surface of the endoscope 300 and can be connected to the LAMS 316 to control deployment of the LAMS 316. The deploy line 314 can compress, restrict, or restrain the LAMS 316 until actuated. Upon actuation, such as through a handle portion of the endoscope 300, the deploy line 314 can release restrained portions of the LAMS 316 to cause the proximal portion 318, the distal portion 320, or both to deploy. Deployment of the LAMS 316 can be achieved by actuating the deploy line 314 to cause a flange of the proximal portion 318, the distal portion 320, or both to extend radially outward from the elongate shaft 302 to engage a tissue wall. The flanges can be formed of a shape memory material, such that as the deploy line 314 is actuated and releases a flange, the flange returns to an uncompressed or unrestricted state and extends radially outward from the endoscope 300. In an example, the deploy line 314 can include separately actuatable proximal and distal segments, such that actuation of the deploy line 314 can release the proximal portion 318 while maintaining the distal portion 320 in a constrained state, and subsequent actuation of the deploy line 314 can release the distal portion 320. The deploy line 314 can be positioned at any location relative to the LAMS 316 that permits actuation of the flanges, such as overlying the LAMS 316, adjacent to the LAMS 316, or underlying the LAMS 316 (e.g., between the LAMS 316 and the elongate shaft 302). The position of the deploy lineGAP25085-GIIV-WO1 (5409.A05W01) 12314 can be selected based on the configuration of the LAMS 316 and the manner in which the deploy line 314 restrains and releases the proximal portion 318 and / or the distal portion 320. In another example, multiple deploy lines can be included to independently deploy the proximal portion 318 and the distal portion 320.

[0047] In other example implementations, the LAMS 316 can be carried on a separate tool or sheath that can be separate from the endoscope 300, or provided in a lumen of the endoscope 300, and can be deployed independent of the endoscope 300.

[0048] The endoscope 300 can include a visual indicator 322 on an outer surface of the elongate shaft 302. The visual indicator 322 can be positioned proximal of the LAMS 316, such as proximal of the proximal portion 318 of the LAMS 316, at a selected distance from the LAMS 316. The selected distance can correspond to a tissue penetration depth such that, when a user observes the visual indicator 322 passing through a target tissue wall (e.g., an inner side of a gastric wall), the LAMS 316 is positioned for deployment of the distal portion 320. The visual indicator 322 can be, for example, a colored line marking visible via endoscopic imaging, a radiopaque marker visible via fluoroscopic imaging, an ultrasound-visible feature visible via ultrasound imaging, or a combination thereof.

[0049] FIGS. 4A-4D illustrate an example flow of using the endoscopic system to create a connection between adjacent body lumens, shown by way of example as a bypass between a small intestine 400 and a stomach 408. The endoscope 300 carrying the proximal and distal portions of the LAMS 316 can be advanced distally via a body lumen toward target tissue, for example using one or more of the onboard endoscopic imaging devices provided on the endoscope 300, fluoroscopic imaging, or the like. In FIG. 4A, the endoscope 300 has been advanced through the small intestine 400 until the tapered distal tip 304 reaches a target region of the wall of the small intestine 400. The LAMS 316 is shown in a pre-installed, constrained state carried at or near the tapered distal tip 304. When the tapered distal tip 304 reaches the target tissue in the desired direction, suction can be activated and utilized through the suction port at the tapered distal tip 304 to draw the target tissue (e.g., the ileal wall) toward the tapered distal tip 304 and, using the applied vacuum, adhere the target tissue to the tapered distal tip 304. The electrode at the tapered distal tip 304 can be energized to deliver RF energy to create a first opening 404 (e.g., a perforation) in the target tissue of the wall of the small intestine 400. The tapered distal tip 304 (and the electrode thereon) can be used to enlarge the first opening 404 by passing the tapered distal tip 304 through the first opening 404 to enlarge it.GAP25085-GIIV-WO1 (5409.A05W01) 13

[0050] The suction port can include a number of openings at different locations along the tapered distal tip 304 and / or the endoscope 300. These openings can contribute both to adhering tissue to the endoscope 300 and to drawing in fluid during the procedure. The locations of the openings can contribute to adhering the ileal wall to the endoscope 300 and / or the tapered distal tip 304 as the endoscope 300 is advanced through the first opening 404. The openings can draw fluid into the endoscope 300 and / or adhere tissue to the endoscope 300 and / or the tapered distal tip 304. In example implementations, the suction port can be provided in a moveable catheter or sheath that can be deployed from the endoscope 300 to implement suction, and the moveable catheter or sheath can be advanced or retracted relative to the endoscope 300 to adjust the location where suction is applied. The adhered tissue can be manipulated with the endoscope 300 and / or the tapered distal tip 304 to be repositioned, pushed, and / or pulled into a desired location.

[0051] In FIG. 4B, the tapered distal tip 304, with the LAMS 316 still carried thereon in the constrained state, has been advanced through the first opening 404 and into the abdominal cavity 406 between the small intestine 400 and the stomach 408. The applied suction through the tapered distal tip 304 can inhibit fluid leakage into the abdominal cavity 406 as the endoscope 300 advances through the first opening 404. The tapered shape of the distal tip 304 can facilitate advancement of the endoscope 300 through the first opening 404. An external fluoroscope, ultrasound probe, and / or the endoscope 300 can capture images of the abdominal cavity 406, which can allow a physician to visualize the location of the stomach 408. The endoscope 300 can be advanced toward a target site on the gastric wall of the stomach 408, and the captured images (e.g., from the distal end scope optics) can help the physician identify and navigate the endoscope 300 past or away from non-target tissue or organs, such as the colon.

[0052] In FIG. 4C, the tapered distal tip 304 has been advanced across the abdominal cavity 406 toward the wall of the stomach 408, and the proximal side 318 of the LAMS 316 has been deployed against the wall of the small intestine 400. As the LAMS 316 reaches the ileal wall, the proximal side 318 of the LAMS 316 can be deployed, for example with actuation via handle operation, where the handle can be connected to the LAMS 316 via the deploy line 314 discussed above in the description of FIG. 3. The deployed proximal side 318 of the LAMS 316 can be positioned against the interior ileal wall, thereby permitting the small intestine 400 to be moved as the tapered distal tip 304 of the endoscope 300 continues to be advanced. Movement of the small intestine 400 can be achieved with the deployed proximal side 318, which can be a flange, and can be assisted or not by the suction being selectively turned on or off in conjunction with the deployed proximal side 318.GAP25085-GIIV-WO1 (5409.A05W01) 14

[0053] Still referring to FIG. 4C, when the tapered distal tip 304 reaches the target tissue (e.g., the gastric wall of the stomach 408), the tapered distal tip 304 can be positioned at or close to the target tissue region of the gastric wall. Suction can be used to manipulate the target tissue region, such as to draw the gastric wall toward and against the tapered distal tip 304 to help provide more precise targeting of the desired portion of the gastric wall tissue. RF energy can be applied via the electrode at the tapered distal tip 304 to penetrate the gastric wall, forming a second opening 412 and allowing the tapered distal tip 304 to enter the stomach 408. The applied suction can collect fluid in the abdominal cavity 406 or the stomach 408. The collection of fluid can help inhibit or prevent gastric fluid from leaking into the abdominal cavity 406 and / or vice versa.

[0054] In FIG. 4D, the tapered distal tip 304 has been advanced through the second opening 412 and into the stomach 408, and the distal side 320 of the LAMS 316 has been deployed within the stomach 408 against the wall of the stomach 408. Once the distal side 320 of the LAMS 316 passes through the inner side of the gastric wall, such as with the passage of the tapered distal tip 304, the distal side 320 of the LAMS 316 can be deployed or expanded, for example by actuating the deploy line 314 discussed above in the description of FIG. 3, for example, via a handle portion of the endoscope 300. In the deployed state shown in FIG. 4D, the proximal side 318 of the LAMS 316 can be expanded against the wall of the small intestine 400, and the distal side 320 of the LAMS 316 can be expanded against the wall of the stomach 408, such that the LAMS 316 extends through the first opening 404, across the abdominal cavity 406, and through the second opening 412 to establish a bypass between the small intestine 400 and the stomach 408. The endoscope 300 can then be withdrawn, leaving the deployed LAMS 316 in place. It is understood that this process is not limited to gastric bypass procedures and can be extended to other medical procedures involving apposing tissue.

[0055] The suction port at the tapered distal tip 304 can create negative pressure to stabilize target tissue, which may assist the procedure during advancement and positioning. The electrode at the tapered distal tip 304 can deliver controlled RF energy, which, for example, can be delivered whether suction is applied or not. In examples, the RF energy is delivered while the applied suction maintains tissue position against the tapered distal tip 304. The RF energy can more precisely target and / or ablate the tissue while the suction secures the tissue in place by suctioning it against the tapered distal tip 304. The tapered shape of the distal tip 304 can help facilitate advancement through the first opening 404 and the second opening 412.GAP25085-GIIV-WO1 (5409.A05W01) 15

[0056] One or more visual indicators (e.g., visual indicator 322 discussed above in the description of FIG. 3), such as a colored line marking, can be included on the endoscope 300 to help assist with proper positioning during the procedure. For example, a red (or otherwise indicated) line marking on the endoscope 300 can serve as a visual reference point to indicate when the endoscope 300 has advanced far enough through the gastric wall for proper LAMS deployment. For example, when this marking passes through the inner side of the gastric wall, it can serve as an indication to a physician that the endoscope 300 is positioned correctly for deploying the distal side 320 of the LAMS 316. The visual indicator can help prevent premature or incorrect stent expansion by providing a clear deployment reference point. In another example, the visual indicator can be a radiopaque marker, an ultrasound visualization, or the like, that can be seen on an external visualization device.

[0057] The example implementation of the sequential deployment of the proximal side 318 and then the distal side 320 of the LAMS 316, as shown progressively in FIGS. 4C and 4D, can help maintain tissue positioning during advancement of the tapered distal tip 304. The distal side 320 of the LAMS 316 can be deployed after confirming proper placement via direct visualization utilizing the endoscopic images from the tapered distal tip 304, ultrasonic imaging, and / or fluoroscopic images. The system can optionally be operated to maintain negative pressure at different levels of suction, for example via a regulator valve. The suction can be controlled, for example via a valve, to be actuated at different intervals before, during, and / or after deployment, or throughout deployment to collect fluid, which can help inhibit or prevent fluid leakage between luminal areas such as the abdominal cavity 406, the stomach 408, and / or the small intestine 400. The suction can contribute to inhibiting leakage during penetration of the intestinal and / or gastric walls.

[0058] As described above, multiple functions can be integrated into the single device. Such integration can help reduce the need for or, in some examples, avoid the use of, multiple separate tools and / or exchanges of devices during the procedure. The system can be used to help create and / or maintain openings between adj acent body lumens and / or provide continuous visualization of the procedure area.

[0059] FIGS. 5-8 illustrate tissue manipulation and LAMS deployment stages that can be carried out using the endoscope 300 described above with respect to FIGS. 3 and 4A-4D, or using an alternative separate deployment device advanced through a working channel of an endoscope. For ease of reference, the following description refers to a deployment device that includes anGAP25085-GIIV-WO1 (5409.A05W01) 16elongate shaft 500; the same tissue manipulation and LAMS deployment stages can be carried out using the endoscope 300 in place of the elongate shaft 500. FIG. 5 illustrates an example of manipulating a first tissue wall 502 relative to a second tissue wall 504 using suction applied through a deployment device that includes an elongate shaft 500 and an RF electrode 506 at a distal end of the elongate shaft 500. A proximal flange 508 of a LAMS can be deployed against a proximal side of the first tissue wall 502. The proximal flange 508 can include an anchoring protrusion 512 on an inner region to engage the first tissue wall 502. Suction applied through an opening at the distal end of the elongate shaft 500 can draw the first tissue wall 502 toward the elongate shaft 500 and can maintain contact between the first tissue wall 502 and the deployment device. The suction can be used to manipulate the first tissue wall 502 with respect to the second tissue wall 504, such as by pushing the first tissue wall 502 toward the second tissue wall 504. Maintaining the first tissue wall 502 in contact with the deployment device via suction can allow the RF electrode 506 to remain positioned for alignment of the first tissue wall 502 with respect to the second tissue wall 504 and for penetration of the first tissue wall 502 by the RF electrode 506. The suction can also be used to inhibit fluid leakage during the procedure.

[0060] The anchoring protrusion 512 can be formed during the manufacturing process of the LAMS, or can be added to an inner region of the proximal flange 508 or of a distal flange alternatively. The anchoring protrusion 512 can be, for example, a portion of a wire protruding from a surface of the LAMS or a particle. In an example, multiple anchoring protrusions 512 can be provided at multiple locations on the proximal flange 508, such as at tips of the proximal flange 508. The anchoring protrusion 512 can contribute to forming a seal between the proximal flange 508 and the first tissue wall 502 that can enhance the effect of the suction drawing the first tissue wall 502 to the opening at the distal end of the elongate shaft 500.

[0061] FIG. 6 illustrates an example of the deployment device positioned between the first tissue wall 502 and the second tissue wall 504 after penetrating through the first tissue wall 502. With the first tissue wall 502 drawn proximally by the suction applied through the opening at the distal end of the elongate shaft 500, a space can be formed between the first tissue wall 502 and the second tissue wall 504. The space can reduce the likelihood that the deployment device contacts or penetrates the second tissue wall 504 as the deployment device advances through the first tissue wall 502. The deployment device can remain in this intermediate position to allow positioning and alignment of the RF electrode 506 with respect to the second tissue wall 504 before forming an opening through the second tissue wall 504. The proximal flange 508 canGAP25085-GIIV-WO1 (5409.A05W01) 17maintain control of the first tissue wall 502 during this positioning phase, for example by engagement of the anchoring protrusion 512 with the first tissue wall 502.

[0062] FIG. 7 illustrates an example of a deployed configuration of the LAMS with the first tissue wall 502 and the second tissue wall 504 secured between the proximal flange 508 and the distal flange 510 of the LAMS. The proximal flange 508 can engage the first tissue wall 502, and the distal flange 510 can extend radially to secure the second tissue wall 504. In an example, the LAMS can assume a concave shape when deployed that can contribute to maintaining apposition of the first tissue wall 502 and the second tissue wall 504. Suction applied through the deployment device can be used to remove fluid during the procedure to inhibit leakage between the first tissue wall 502 and the second tissue wall 504. The deployment device can be withdrawn after deployment of the LAMS, leaving the LAMS in place to maintain a connection between the first tissue wall 502 and the second tissue wall 504.

[0063] FIG. 8 illustrates an example of a final deployed state of the LAMS after the deployment device (e.g., the endoscope or the catheter, if applicable) has been withdrawn. The proximal flange 508 can engage the first tissue wall 502 and the distal flange 510 can engage the second tissue wall 504, with the first tissue wall 502 and the second tissue wall 504 held between the proximal flange 508 and the distal flange 510. A central portion of the LAMS can extend through the opening formed in the first tissue wall 502 and the opening formed in the second tissue wall 504 to maintain a connection between the first tissue wall 502 and the second tissue wall 504. The LAMS can define a central passage that can allow exchange of fluid between a first body lumen bounded by the first tissue wall 502 and a second body lumen bounded by the second tissue wall 504. After withdrawal of the deployment device, the deployed LAMS can maintain the connection between the first tissue wall 502 and the second tissue wall 504.

[0064] FIG. 9 illustrates an example method 900 for creating a connection between adjacent body lumens. The method can include or comprise a number of Operations. The Operations described herein are examples only, and the method can omit one or more of the listed Operations, can repeat Operations, or can include other Operations. The Operations can be executed concurrently, substantially simultaneously, or in another order as appropriate or desired.

[0065] At Operation 902, the method 900 can include advancing an endoscope toward a first tissue wall of a first body lumen. The advancing can be performed under endoscopic visualization, fluoroscopic visualization, ultrasound visualization, or a combination thereof. In an example, the first body lumen can be a lumen of the small intestine, such as the ileum orGAP25085-GIIV-WO1 (5409.A05W01) 18jejunum. The endoscope can be advanced distally toward the first tissue wall. In another example, a catheter can be advanced from the endoscope distally toward the first tissue wall . The advancing can include navigating a distal end of the endoscope past non-target tissue or organs using images captured by an imaging device at the distal end of the endoscope.

[0066] At Operation 904, the method 900 can include applying suction to grasp the first tissue wall. The suction can be applied through a suction port at a distal end of the endoscope, through a suction lumen of a deployment device, through a working channel of the endoscope, or through another suction member. The suction can draw the first tissue wall into contact with the distal end of the endoscope and can adhere the first tissue wall to the distal end of the endoscope to stabilize the first tissue wall for subsequent Operations. The suction can also be used to help reduce, mitigate, or inhibit fluid leakage during the procedure.

[0067] At Operation 906, the method 900 can include forming a first opening through the first tissue wall. The first opening can be formed using one or more electrodes at the distal end of the endoscope, such as by delivering RF energy to cut and / or cauterize the first tissue wall. The suction can be maintained during formation of the first opening to stabilize the first tissue wall and to help inhibit fluid leakage. In examples, other opening formation techniques can be used, such as a needle, a movable or fixed blade, rotational cutting, or the like. A tapered portion of the distal end of the endoscope can enlarge the first opening as the distal end of the endoscope passes through the first opening.

[0068] At Operation 908, the method 900 can include deploying a proximal portion of a LAMS against a proximal side of the first tissue wall. The LAMS can be pre-installed on the endoscope, attached to or mounted on an outer surface of the endoscope, or deployable from a sheath provided in a lumen of the endoscope. The deploying can include actuating a deploy line coupled or connected to the LAMS to release the proximal portion of the LAMS, retracting a sheath to allow expansion of the proximal portion of the LAMS, or both. The proximal portion of the LAMS can include a proximal flange that, when deployed, extends radially outward to engage the first tissue wall. The proximal flange can include one or more anchoring protrusions on an inner region to engage the first tissue wall.

[0069] At Operation 910, the method 900 can include advancing the endoscope toward a second tissue wall of a second body lumen. In an example, the second body lumen can be a lumen of the stomach. The deployed proximal portion of the LAMS can lift or move the first tissue wall as the endoscope is advanced. The advancing can be performed under visualization provided by anGAP25085-GIIV-WO1 (5409.A05W01) 19imaging device at the distal end of the endoscope, an external fluoroscope, an ultrasound probe, or a combination thereof, to navigate past non-target tissue or organs such as the colon.

[0070] At Operation 912, the method 900 can include applying suction to grasp the second tissue wall. The suction can draw the second tissue wall into contact with the distal end of the endoscope to stabilize the second tissue wall and to position the second tissue wall relative to the first tissue wall. In an example, the suction can be used to manipulate the second tissue wall, such as by pulling the second tissue wall toward the first tissue wall. Alternatively or additionally, the endoscope or the proximal portion of the LAMS can be advanced to urge the first tissue wall toward the second tissue wall. A gap between the first tissue wall and the second tissue wall can be sized or adjusted as appropriate for a particular procedure. In some procedures, the first tissue wall and the second tissue wall can be pulled into direct apposition or contact with each other, such as to form a tight anastomosis. In other procedures, a gap can be maintained between the first tissue wall and the second tissue wall, such as to accommodate anatomical spacing between the first body lumen and the second body lumen or to allow the LAMS to span a working distance between non-adjacent structures. For example, in a gastrojejunostomy or gastroduodenostomy procedure, the first tissue wall and the second tissue wall may be drawn into direct apposition to form a passageway for gastrointestinal contents. In a gallbladder drainage procedure (e.g., cholecystoduodenostomy or cholecystogastrostomy) or a pancreatic pseudocyst drainage procedure, a gap between the first tissue wall and the second tissue wall may be maintained so that the LAMS serves as a drainage conduit across the gap.

[0071] At Operation 914, the method 900 can include forming a second opening through the second tissue wall. The second opening can be formed using the one or more electrodes at the distal end of the endoscope, such as by delivering RF energy to cut and / or cauterize the second tissue wall. The suction can be maintained during formation of the second opening to stabilize the second tissue wall and to inhibit fluid leakage between the first body lumen and the second body lumen. In examples, other opening formation techniques can be used, such as a needle, a movable or fixed blade, rotational cutting, or the like.

[0072] At Operation 916, the method 900 can include deploying a distal portion of the LAMS against a distal side of the second tissue wall to create a connection between the first body lumen and the second body lumen. The deploying can include actuating the deploy line coupled to the LAMS to release the distal portion of the LAMS, advancing a sheath to allow expansion of the distal portion of the LAMS, or both. The distal portion of the LAMS can include a distal flangeGAP25085-GIIV-WO1 (5409.A05W01) 20that, when deployed, extends radially outward to engage the second tissue wall. A visual indicator on the endoscope, such as a colored line marking, a radiopaque marker, or an ultrasound-visible feature, can be observed to confirm that the distal end of the endoscope has advanced a selected distance through the second opening before deploying the distal portion of the LAMS. The gap between the first tissue wall and the second tissue wall can be adjusted before, during, or after deployment of the distal portion of the LAMS to fit the LAMS to the tissue walls and openings and to achieve a selected spacing between the first tissue wall and the second tissue wall for the particular procedure. The endoscope can then be withdrawn, leaving the LAMS in place to maintain the connection between the first body lumen and the second body lumen.

[0073] The above detailed description includes references to the accompanying drawings, which form a part of the detailed description. The drawings show, by way of illustration, specific embodiments that may be practiced. These embodiments are also referred to herein as “examples.” Such examples may include elements in addition to those shown or described. However, the present inventors also contemplate examples in which only those elements shown or described are provided. Moreover, the present inventors also contemplate examples using any combination or permutation of those elements shown or described (or one or more aspects thereof), either with respect to a particular example (or one or more aspects thereof), or with respect to other examples (or one or more aspects thereof) shown or described herein.ADDITIONAL NOTES

[0074] In this document, the terms “a” or “an” are used, as is common in patent documents, to include one or more than one, independent of any other instances or usages of “at least one” or “one or more.” In this document, the term “or” is used to refer to a nonexclusive or, such that “A or B” includes “A but not B,” “B but not A,” and “A and B,” unless otherwise indicated. In the appended claims, the terms “including” and “in which” are used as the plain-English equivalents of the respective terms “comprising” and “wherein.” Also, in the following claims, the terms “including” and “comprising” are open-ended, that is, a system, device, article, or process that includes elements in addition to those listed after such a term in a claim are still deemed to fall within the scope of that claim. Moreover, in the following claims, the terms “first,” “second,” and “third,” etc. are used merely as labels, and are not intended to impose numerical requirements on their objects.

[0075] The above description is intended to be illustrative, and not restrictive. For example, the above-described examples (or one or more aspects thereof) may be used in combinationGAP25085-GIIV-WO1 (5409.A05W01) 21with each other. Other embodiments may be used, such as by one of ordinary skill in the art upon reviewing the above description. The Abstract is to allow the reader to quickly ascertain the nature of the technical disclosure and is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. Also, in the above Detailed Description, various features may be grouped together to streamline the disclosure. This should not be interpreted as intending that an unclaimed disclosed feature is essential to any claim. Rather, inventive subject matter may lie in less than all features of a particular disclosed embodiment. Thus, the following claims are hereby incorporated into the Detailed Description, with each claim standing on its own as a separate embodiment. The scope of the embodiments should be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled.GAP25085-GIIV-WO1 (5409.A05W01) 22

Claims

CLAIMSWhat is claimed is:

1. A system comprising:an endoscope with a distal tip;a suction port accessible to the distal tip;an electrode positioned on the distal tip;a lumen-apposing stent, carried by the endoscope and positionable near the distal tip; andan actuator coupled to the lumen-apposing stent and configured to deploy a proximal portion of the lumen-apposing stent independently of a distal portion of the lumen-apposing stent.

2. The system of claim 1, wherein the distal tip is a tapered distal tip.

3. The system of claim 1 or 2, wherein the electrode is configured to deliver radiofrequency energy while suction is being applied through the suction port.

4. The system of any of claims 1 to 3, wherein the electrode includes a plurality of discrete electrodes, and wherein at least two of the plurality of discrete electrodes are arranged around an opening of the suction port.

5. The system of any one of claims 1 to 4, wherein at least a portion of the distal tip functions as the electrode such that advancement of the distal tip through a tissue opening enlarges the tissue opening.

6. The system of any one of claims 1 to 5, further comprising:a deploy line extending along at least a portion of the endoscope and coupled to the lumen-apposing stent, wherein the deploy line is configured to restrain the lumen-apposing stent and, wherein upon actuation of the actuator, the deploy line is configured to release at least one of the proximal portion and the distal portion.

7. The system of claim 6, wherein the deploy line includes separately actuatable GAP25085-GIIV-WO1 (5409.A05W01) 23proximal and distal segments, the proximal segment configured to release the proximal portion and the distal segment configured to release the distal portion.

8. The system of claim 1, further comprising:one or more visual indicators located on an outer surface of the endoscope, wherein the one or more visual indicators are located for positioning the lumen-apposing stent during deployment.

9. The system of claim 8, wherein the one or more visual indicators includes one or more of i) a colored line marking visible via endoscopic imaging, ii) a radiopaque marker visible via fluoroscopic imaging, or iii) an ultrasound-visible feature visible via ultrasound imaging.

10. The system of any one of claims 1 to 9, wherein:the proximal portion of the lumen-apposing stent includes a proximal flange;the distal portion of the lumen-apposing stent includes a distal flange; andat least one of the proximal flange and the distal flange is formed of a shape memory material configured to extend radially outward from the endoscope upon release.

11. The system of any of claims 1 to 10, wherein the suction port is configured to maintain negative pressure during deployment of the lumen-apposing stent.

12. The system of any of claims 1 to 11, wherein the actuator includes a handle operable for deploying the lumen-apposing stent.

13. The system of any of claims 1 to 12, wherein the lumen-apposing stent is mounted on an outer surface of the endoscope.

14. The system of any of claims 1 to 13, further comprising:a camera; anda light source, wherein the camera and the light source are located in or near the distal tip, wherein the camera is configured to capture images of an anatomical region, and wherein the light source is configured to illuminate the anatomical region.GAP25085-GIIV-WO1 (5409.A05W01) 2415. The system of any of claims 1 to 14, wherein the suction port defines an opening at the distal tip and the electrode is positioned around the opening of the suction port such that suction applied through the suction port and radiofrequency energy delivered from the electrode act on a common tissue region.

16. A system comprising:an endoscope with a tapered distal tip;a suction port defining an opening in the tapered distal tip and connectable to a suction source;an electrode positioned around the opening of the suction port and connectable to an electrosurgical generator, wherein at least a portion of the tapered distal tip functions as the electrode such that advancement of the tapered distal tip through a tissue enlarges a tissue opening;a lumen-apposing stent mounted on an outer surface of the endoscope proximate the tapered distal tip, wherein the lumen-apposing stent includes a proximal portion and a distal portion; anda deploy line extending along at least a portion of the endoscope and coupled to the lumen-apposing stent.

17. The system of claim 16, further comprising:one or more visual indicators located on an outer surface of the endoscope proximal of the lumen-apposing stent, wherein the one or more visual indicators are positioned to indicate when the tapered distal tip has advanced through a tissue wall for deployment of the distal portion of the lumen-apposing stent.

18. The system of claim 16 or 17, wherein:the proximal portion of the lumen-apposing stent includes a proximal flange; the distal portion of the lumen-apposing stent includes a distal flange;and at least one of the proximal flange and the distal flange is formed of a shape memory material configured to extend radially outward from the endoscope upon release by the deploy line.

19. The system of any of claims 16 to 18, wherein:GAP25085-GIIV-WO1 (5409.A05W01) 25the deploy line is configured to deploy the proximal portion independently of the distal portion;the deploy line includes separately actuatable proximal and distal segments;the proximal segment is configured to release the proximal portion; andthe distal segment is configured to release the distal portion.

20. The system of any of claims 16 to 19, further comprising:a handle coupled to the deploy line and operable to actuate the deploy line to release the proximal portion of the lumen-apposing stent in a first actuation and to release the distal portion of the lumen-apposing stent in a second actuation subsequent to the first actuation.

21. A method of deploying a lumen-apposing stent using the system of any of claims 1 to 20, the method comprising:applying suction through the suction port to draw a wall of a first body lumen toward the distal tip;delivering radiofrequency energy from the electrode to form a first opening in the wall of the first body lumen;advancing the distal tip through the first opening;deploying the proximal portion of the lumen-apposing stent against the wall of the first body lumen;applying suction through the suction port to draw a wall of a second body lumen toward the distal tip;delivering radiofrequency energy from the electrode to form a second opening in the wall of the second body lumen; anddeploying the distal portion of the lumen-apposing stent against the wall of the second body lumen.GAP25085-GIIV-WO1 (5409.A05W01) 26